Alpha-particle therapy shows preclinical promise against bladder cancer cells
A preclinical study reports that 213Bi-labeled trastuzumab plus cetuximab killed human bladder cancer cells in vitro through irreparable DNA damage.
Tag: BCG failure
POPULAR NEWS
-
Inflammation-Weighted Nutrition Score Predicts Survival After Liver Cancer Surgery
-
RAS Inhibitor Daraxonrasib Redefines Pancreatic Cancer Treatment After FDA Approval
-
Few Ethiopian Mothers Receive Quality Care Across Maternity Continuum
-
Particle Swarm Optimization Steers Client Selection in Decentralized Federated Learning